ClassPass expands into wellness experiences, FDA reviews BPC-157

ClassPass is pushing into self-care and experiences, moving beyond just fitness classes. Meanwhile, the FDA is meeting to assess regulatory changes for peptides like BPC-157, and Neko Health just secured $700 million Series C funding ahead of its US launch.